153 related articles for article (PubMed ID: 37936655)
1. Experiences of reduction and discontinuation of antipsychotics: a qualitative investigation within the RADAR trial.
Morant N; Long M; Jayacodi S; Cooper R; Akther-Robertson J; Stansfeld J; Horowitz M; Priebe S; Moncrieff J
EClinicalMedicine; 2023 Oct; 64():102135. PubMed ID: 37936655
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial.
Moncrieff J; Crellin N; Stansfeld J; Cooper R; Marston L; Freemantle N; Lewis G; Hunter R; Johnson S; Barnes T; Morant N; Pinfold V; Smith R; Kent L; Darton K; Long M; Horowitz M; Horne R; Vickerstaff V; Jha M; Priebe S
Lancet Psychiatry; 2023 Nov; 10(11):848-859. PubMed ID: 37778356
[TBL] [Abstract][Full Text] [Related]
3. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
[TBL] [Abstract][Full Text] [Related]
4. A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities.
McNamara R; Randell E; Gillespie D; Wood F; Felce D; Romeo R; Angel L; Espinasse A; Hood K; Davies A; Meek A; Addison K; Jones G; Deslandes P; Allen D; Knapp M; Thapar A; Kerr M
Health Technol Assess; 2017 Aug; 21(47):1-92. PubMed ID: 28857740
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
[TBL] [Abstract][Full Text] [Related]
8. The subjective effect of antipsychotic medication on trauma-related thoughts, emotions, and physical symptoms: A qualitative study with people who have experienced childhood trauma and psychosis.
Kamitsis I; Harms L; Bendall S
Psychol Psychother; 2022 Mar; 95(1):256-276. PubMed ID: 34617384
[TBL] [Abstract][Full Text] [Related]
9. Mental health professionals' views and experiences of antipsychotic reduction and discontinuation.
Cooper RE; Hanratty É; Morant N; Moncrieff J
PLoS One; 2019; 14(6):e0218711. PubMed ID: 31220160
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
12. Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.
Gumley AI; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Birchwood M; Briggs A; Bucci S; Cotton S; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Reilly F; Schwannauer M; Singh SP; Sundram S; Thompson A; Williams C; Yung A; Aucott L; Farhall J; Gleeson J
Health Technol Assess; 2022 May; 26(27):1-174. PubMed ID: 35639493
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia.
Van Leeuwen E; Petrovic M; van Driel ML; De Sutter AI; Vander Stichele R; Declercq T; Christiaens T
Cochrane Database Syst Rev; 2018 Apr; 3(3):CD007726. PubMed ID: 29605970
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
[TBL] [Abstract][Full Text] [Related]
15. A qualitative exploration of family members' perspectives on reducing and discontinuing antipsychotic medication.
Lewins A; Morant N; Akther-Robertson J; Crellin NE; Stansfeld JL; Smith R; Moncrieff J
J Ment Health; 2022 May; ():1-8. PubMed ID: 35521675
[TBL] [Abstract][Full Text] [Related]
16. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
[TBL] [Abstract][Full Text] [Related]
17. Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.
Thompson J; Stansfeld JL; Cooper RE; Morant N; Crellin NE; Moncrieff J
Soc Psychiatry Psychiatr Epidemiol; 2020 Feb; 55(2):151-164. PubMed ID: 31875238
[TBL] [Abstract][Full Text] [Related]
18. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
[TBL] [Abstract][Full Text] [Related]
19. Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu A; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Romeo R; Gray R
Health Technol Assess; 2018 Nov; 22(67):1-62. PubMed ID: 30507375
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
